Lene Dreyer - Concepedia

Author

Lene Dreyer

Also Known As

Dreyer, L, Dreyer, Lene, Dreyer, Lene Wohlfahrt, L Dreyer, L Wohlfahrt Dreyer, L. DREYER, L. Dreyer, LW Dreyer, Lene Dreyer, Lene W. Dreyer

307

Publications

Citations

H-Index

105

Concepts

All Affiliations

Rigshospitalet Gentofte Hospital Frederiksberg Hospital Aalborg University Hospital University of Copenhagen

About

Lene Dreyer is an author at Rigshospitalet specializing in medicine, public health, and epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	24	1.2K
2	Public Health	13	13	743
3	Health Sciences	4	4	249
4	Applied Physiology	2	2	104
5	Allergy	1	1	37

Lene Dreyer

105

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry Merete Lund Hetland, Ib Jarle Christensen, Ulrik Tarp, Arthritis & Rheumatism	2009	529
Cancer risk in systemic lupus: An updated international multi-centre cohort study Sasha Bernatsky, Rosalind Ramsey‐Goldman, Jeremy A. Labrecque, Journal of Autoimmunity EpidemiologyCancer RiskCancer EpidemiologySystemic Lupus ErythematosusSystemic Lupus Erythematosus Treatment	2013	294
Treatment response, drug survival, and predictors thereof in 764 patients with psoriatic arthritis treated with anti–tumor necrosis factor α therapy: Results from the nationwide Danish DANBIO registry Bente Glintborg, Mikkel Østergaard, Lene Dreyer, Arthritis & Rheumatism	2010	243
Predictors of treatment response and drug continuation in 842 patients with ankylosing spondylitis treated with anti-tumour necrosis factor: results from 8 years' surveillance in the Danish nationwide DANBIO registry Bente Glintborg, Mikkel Østergaard, Niels Steen Krogh, Annals of the Rheumatic Diseases	2010	220
Long‐term mortality and renal outcome in a cohort of 100 patients with Lupus Nephritis Mikkel Faurschou, Lene Dreyer, Anne‐Lise Kamper, Arthritis Care & Research	2010	211
Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers Louise Mercer, Johan Askling, Pauline Raaschou, Annals of the Rheumatic Diseases	2016	182
Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides – a follow-up study from the DANBIO Registry Lene Dreyer, Lene Mellemkjær, Anne Rødgaard Andersen, Annals of the Rheumatic Diseases	2012	175
Lymphoma risk in systemic lupus: effects of disease activity versus treatment Sasha Bernatsky, Rosalind Ramsey‐Goldman, Lawrence Joseph, Annals of the Rheumatic Diseases	2013	156
Increased morbidity from ischemic heart disease in patients with Wegener's granulomatosis Mikkel Faurschou, Lene Mellemkjær, Inge Juul Sørensen, Arthritis & Rheumatism	2009	146
Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the ‘JAK-pot’ collaboration Kim Lauper, Michele Iudici, Denis Mongin, Annals of the Rheumatic Diseases	2022	138

Page 1